

"Global biotechnology leader providing life science services from gene synthesis to drug development"
GenScript Biotech Corporation accelerates innovation in biotechnology and healthcare by providing researchers and companies with essential building blocks for groundbreaking treatments. As the largest gene synthesis provider in the United States since 2008, GenScript delivers comprehensive services spanning DNA synthesis, protein production, antibody development, CRISPR genome editing, and mRNA services, serving over 200,000 customers across 100 countries. Through its integrated platform, GenScript transforms scientific possibilities into solutions that advance drug discovery and therapeutic development. The company operates through core segments providing research services, enzyme engineering, and CDMO for cell and gene therapies.


6900
Team Members
2002
Founded
Contract Research
Sector
On-Site
Work Environment
A world where biotechnology transforms bold scientific possibilities into realities that heal and sustain humanity and nature, advancing life science solutions that drive meaningful progress and lasting impact across global healthcare.
At GenScript, our mission is to make people and nature healthier through biotechnology, advancing innovative life science solutions that drive progress and impact.